New Technology Add-On Payments ─ Don't Miss your Opportunity to Comment!

By Indya Miller, CCS, Outpatient Compliance Manager, Axea Solutions

CMS is modifying the approach for presenting the new technology add-on payment (NTAP) related ICD-10-PCS procedure code requests that involve the administration of a therapeutic agent for the March 9-10, 2021 ICD-10 Coordination and Maintenance Committee meeting.

​CMS is soliciting public comments in advance of the meeting. Be sure not to miss your opportunity to participate. 

​To accommodate the number of requests received for the March 9-10, 2021 ICD-10 Coordination and Maintenance Committee meeting, CMS is only displaying those meeting materials with the six NTAP related ICD-10-PCS procedure code requests that involve the administration of a therapeutic agent, which are:
 

1. Administration of Trilaciclib
2. Administration of ZEPZELCATM (lurbinectedin)
3. Administration of ENSPRYNGTM (satralizumab-mwge)
4. Administration of Ciltacabtagene Autoleucel (cilta-cel)
5. Administration of Amivantamab
6. Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (PRCFC)

 
These materials are now available on the CMS website.  The topic specifics will not be presented during the March 9-10, 2021 meeting. CMS is soliciting public comments regarding any clinical questions or coding options included for these six procedure code topics in advance of the meeting, continuing through the end of the public comment period, April 9, 2021.

Members of the public should send any questions or comments to the CMS mailbox at: ICDProcedureCodeRequest@cms.hhs.gov
 

---